I am Mohamed Mostafa Kamal, PhD, a Professor of Biochemistry, Faculty of Pharmacy, Pharmacology and Biochemistry Department, The British University in Egypt. As a pharmacist and a biochemist, I have been interested in modern applications of biochemistry in understanding disease molecular mechanisms and new theraputic modalities. I have got my PhD on targeting can stem cells in one of the deadliest brain tumors, namely glioblastoma multiforme. I did this study in USA. After getting back home to Egypt, I managed to initiate a whole stem cell line of research where we are studying different sources of mesenchymal stem cells such as Wharton' s jelly, umbilical cord, adipose tissue and recently periodontal ligament. We are differentiating these into insulin producing cells, bones and hepatocytes studying factors and differentiating agents that can trans differentiate these cells. Also, we studied the SNPs effects of some genes on susceptibility to diabetes and tissue graft failure. Besides, we have a lot of work on exploring new diagnostic and prognostic markers as a gene/long non-coding RNA axis in colorectal and breast cancer. In addition, we are working on developing new miRNA based therapeutic target for breast cancer. As an active researcher, I have published almost 30 peer-reviewed papers in decent journals all are Scopus indexed. Now, my citations have exceeded the 600 citations (as October 2024). I have participated in more than 30 international conferences, inside and outside Egypt. My Google Scholar H-index is 15. I have got several awards including the British University Early Career Research Award in 2022, The BioScience Pharmaceutical Science Award in 2023, The International Conference Grant from the British University in Egypt. I am a member in the International Society of Gene and Cell therapy (ISCT), the International Society of Stem Cell Research (ISSCR), The Endocrine Society (ENDO) and The Egyptian Society of Clinical Chemistry (ESCC). Besides, I have been an Editor Reviewer in Frontiers. I have reviewed in more than 10 journals such as : (1) New England Journal of Medicine (IF: 72.406, NEJM); (2) Cellular Biochemistry (IF: 3.085 , Wiley Online Library); (3) Bioanalysis (IF: 2.673, Future Medicine); (4) BMJ Open Diabetes Research and Care (IF: 5.067, BMJ Journals); (5) Cell Biochemistry and Biophysics (IF: 1.455, Springer); (6) Cellular Physiology and Biochemistry (IF: 1.303); (7) Journal of Gastrointestinal Cancer (IF 2.892); (8) Frontiers in Immunology (IF 6.429); (9) BMJ Open Diabetes Research and Care (IF 3.21); (10) Biomed Research International (IF 3.411); (11) Frontiers In Molecular Neuroscience (IF 5.639); (12) Frontiers Genetics; (13) Heylion; (14) Frontiers Bioengineering; and (15) Journal of Biological Macromolecules. In the future, I am aiming to pursue my stem cell research using commercially available stem cells lines including mesenchymal and induced pluripotent stem cells. I hope to build up a team to explore the differentiation mechanisms of these stem cells aiming to produce mature functional cells such as insulin producing cells or osteocytes for treatment of various diseases. I can apply new gene editing tools such as CRISPR-Cas9 to produce genetically modified, clinical grade stem cells suitable for clinical applications. One can collaborate with other USA institutes undergoing clinical applications of stem cells as a translational step in the clinical applications of stem cell. As for cancer and/diabetes research, I am aiming to explore the potential mechanisms especially the one involving cancer stem cells and non-coding RNAs namely microRNAs and long non-coding RNA (lncRNAs) as potential drivers of such diseases using bioinformatics and computational biology tools. In addition, we can explore how targeting these gene modifiers either alone of nanoparticles loaded, can be a potential therapy for these diseases. I have been in the academia since my graduation in 2001. I have built my own professional toolbox over these long years. This includes expertise in research methodology and placing research questions and designing the experiments and methods to answer these questions. Also, I have been implementing experiments in cell biology, stem cells, qRT-PCR, nucleic acids extraction, protein assays including western blotting and ELISA. All of this comes with excellent presentation, communications skills and scientific writing skills. Also, I have the basics of bioinformatics including searching databases and designing primers for PCR reactions. I have mentored almost 20 Ph.D. or M.Sc. students beside undergraduate graduation projects. For these students, I was keen to develop and support their technical, writing, presentation skills. I have been a director of Drug Research and Development center since 2019 which is a proof of my mangerial and leadership abilities. I love reading, swimming and football. I also work out twice a week. I love reading books.